Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter?

References

1. 1.↵
   2. deToledo-Morrell L,
   3. Stoub TR,
   4. Bulgakova M, et al

   . MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004;25:1197–203 doi:10.1016/j.neurobiolaging.2003.12.007 pmid:15312965

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Fritzsche KH,
   3. Stieltjes B,
   4. Schlindwein S, et al

   . Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment. Int J Comput Assist Radiol Surg 2010;5:623–32 doi:10.1007/s11548-010-0412-0 pmid:20440655

   CrossRefPubMed
3. 3.↵
   2. Douaud G,
   3. Menke RA,
   4. Gass A, et al

   . Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease. J Neurosci 2013;33:2147–55 doi:10.1523/JNEUROSCI.4437-12.2013 pmid:23365250

   Abstract/FREE Full Text
4. 4.↵
   2. Wang PN,
   3. Lirng JF,
   4. Lin KN, et al

   . Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan. Neurobiol Aging 2006;27:1797–806 doi:10.1016/j.neurobiolaging.2005.10.002 pmid:16321457

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Eckerström C,
   3. Olsson E,
   4. Borga M, et al

   . Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Göteborg MCI study. J Neurol Sci 2008;272:48–59 doi:10.1016/j.jns.2008.04.024 pmid:18571674

   CrossRefPubMed
6. 6.↵
   2. Varon D,
   3. Barker W,
   4. Loewenstein D, et al

   ; Alzheimer's Disease Neuroimaging Initiative. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome. Int J Geriatr Psychiatry 2015;30:192–200 doi:10.1002/gps.4126 pmid:24816477

   CrossRefPubMed
7. 7.↵
   2. Jack CR Jr.,
   3. Shiung MM,
   4. Weigand SD, et al

   . Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65:1227–31 doi:10.1212/01.wnl.0000180958.22678.91 pmid:16247049

   Abstract/FREE Full Text
8. 8.↵
   2. Desikan RS,
   3. Fischl B,
   4. Cabral HJ, et al

   . MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. Neurology 2008;71:819–25 doi:10.1212/01.wnl.0000320055.57329.34 pmid:18672473

   Abstract/FREE Full Text
9. 9.↵
   2. Devanand DP,
   3. Pradhaban G,
   4. Liu X, et al

   . Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007;68:828–36 doi:10.1212/01.wnl.0000256697.20968.d7 pmid:17353470

   Abstract/FREE Full Text
10. 10.↵
    2. Petrella JR,
    3. Coleman RE,
    4. Doraiswamy PM

    . Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315–36 doi:10.1148/radiol.2262011600 pmid:12563122

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Petrella JR

    . Neuroimaging and the search for a cure for Alzheimer disease. Radiology 2013;269:671–91 doi:10.1148/radiol.13122503 pmid:24261497

    CrossRefPubMed
12. 12.↵
    2. Liu Y,
    3. Paajanen T,
    4. Zhang Y, et al

    ; Addneuromed Consortium. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2010;31:1375–85 doi:10.1016/j.neurobiolaging.2010.01.022 pmid:20447732

    CrossRefPubMed
13. 13.↵
    2. Ross DE,
    3. Ochs AL,
    4. Seabaugh JM, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Man versus machine: comparison of radiologists' interpretations and NeuroQuant® volumetric analyses of brain MRIs in patients with traumatic brain injury. J Neuropsychiatry Clin Neurosci 2013;25:32–39 doi:10.1176/appi.neuropsych.11120377 pmid:23487191

    CrossRefPubMed
14. 14.↵
    2. Davatzikos C,
    3. Fan Y,
    4. Wu X, et al

    . Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging 2008;29:514–23 doi:10.1016/j.neurobiolaging.2006.11.010 pmid:17174012

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Misra C,
    3. Fan Y,
    4. Davatzikos C

    . Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009;44:1415–22 doi:10.1016/j.neuroimage.2008.10.031 pmid:20594615

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Davatzikos C,
    3. Bhatt P,
    4. Shaw LM, et al

    . Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 2011;32::2322.e19–27 doi:10.1016/j.neurobiolaging.2010.05.02327 pmid:20594615

    CrossRefPubMed
17. 17.↵
    2. Vemuri P,
    3. Wiste HJ,
    4. Weigand SD, et al

    ; Alzheimer's Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 2009;73:294–301 doi:10.1212/WNL.0b013e3181af79fb pmid:19636049

    Abstract/FREE Full Text
18. 18.↵
    2. Plant C,
    3. Teipel SJ,
    4. Oswald A, et al

    . Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage 2010;50:162–74 doi:10.1016/j.neuroimage.2009.11.046 pmid:19961938

    CrossRefPubMed
19. 19.↵
    2. Fennema-Notestine C,
    3. McEvoy LK,
    4. Hagler DJ Jr.

    ; The Alzheimer's Disease Neuroimaging Initiative. Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. Behav Neurol 2009;21:3–12 doi:10.1155/2009/698156 pmid:19847040

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Moradi E,
    3. Pepe A,
    4. Gaser C, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects. Neuroimage 2015;104:398–412 doi:10.1016/j.neuroimage.2014.10.002 pmid:25312773

    CrossRefPubMed
21. 21.↵
    2. Zhan Y,
    3. Chen K,
    4. Wu X, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Identification of conversion from normal elderly cognition to Alzheimer's disease using multimodal support vector machine. J Alzheimers Dis 2015;47:1057–67 doi:10.3233/JAD-142820 pmid:26401783

    CrossRefPubMed
22. 22.↵
    2. Adaszewski S,
    3. Dukart J,
    4. Kherif F, et al

    ; Alzheimer's Disease Neuroimaging Initiative. How early can we predict Alzheimer's disease using computational anatomy? Neurobiol Aging 2013;34:2815–26 doi:10.1016/j.neurobiolaging.2013.06.015 pmid:23890839

    CrossRefPubMed
23. 23.↵
    2. Ahdidan J,
    3. Raji CA,
    4. DeYoe EA, et al

    . Quantitative neuroimaging software for clinical assessment of hippocampal volumes on MRI. J Alzheimers Dis 2015;49:723–32 doi:10.3233/JAD-150559 pmid:26484924

    CrossRefPubMed
24. 24.↵
    2. Brewer JB,
    3. Magda S,
    4. Airriess C, et al

    . Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 2009;30:578–80 doi:10.3174/ajnr.A1402 pmid:19112065

    Abstract/FREE Full Text
25. 25.↵
    2. Ahdidan J,
    3. Hviid LB,
    4. Chakravarty MM, et al

    . Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder. Acta Psychiatr Scand 2011;123:211–19 doi:10.1111/j.1600-0447.2010.01644.x pmid:21219263

    CrossRefPubMed
26. 26.↵
    2. DeLong ER,
    3. DeLong DM,
    4. Clarke-Pearson DL

    . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45 doi:10.2307/2531595 pmid:3203132

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Breiman L

    . Random forests. Machine Learning 2001;45:5–32 doi:10.1023/A:1010933404324

    CrossRefWeb of Science
28. 28.↵
    2. Heister D,
    3. Brewer JB,
    4. Magda S, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 2011;77:1619–28 doi:10.1212/WNL.0b013e3182343314 pmid:21998317

    Abstract/FREE Full Text
29. 29.↵
    2. Risacher SL,
    3. Saykin AJ,
    4. West JD, et al

    ; Alzheimer's Disease Neuroimaging Initiative (ADNI). Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 2009;6:347–61 doi:10.2174/156720509788929273 pmid:19689234

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Yi HA,
    3. Moller C,
    4. Dieleman N, et al

    . Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease. J Neurol Neurosurg Psychiatry 2016;87:425–32 doi:10.1136/jnnp-2014-309105 pmid:25904810

    Abstract/FREE Full Text
31. 31.↵
    2. Macdonald KE,
    3. Bartlett JW,
    4. Leung KK, et al

    ; ADNI investigators. The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD. Alzheimer Dis Assoc Disord 2013;27:168–73 doi:10.1097/WAD.0b013e318260a79a pmid:22760170

    CrossRefPubMed
32. 32.↵
    2. Karas G,
    3. Sluimer J,
    4. Goekoop R, et al

    . Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944–49 doi:10.3174/ajnr.A0949 pmid:18296551

    Abstract/FREE Full Text
33. 33.↵
    2. Wyman BT,
    3. Harvey DJ,
    4. Crawford K, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement 2013;9:332–37 doi:10.1016/j.jalz.2012.06.004 pmid:23110865

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Hill DL,
    3. Schwarz AJ,
    4. Isaac M, et al

    . Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. Alzheimers Dement 2014;10:21–9.e3 doi:10.1016/j.jalz.2013.07.003 pmid:24985687

    CrossRefPubMed
35. 35.↵
    2. Hawkins DM

    . The problem of overfitting. J Chem Inf Comput Sci 2004;44:1–12 doi:10.1021/ci0342472 pmid:14741005

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Gomar JJ,
    3. Bobes-Bascaran MT,
    4. Conejero-Goldberg C, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Gen Psychiatry 2011;68:961–69 doi:10.1001/archgenpsychiatry.2011.96 pmid:21893661

    CrossRefPubMedWeb of Science